Jyoti Wadhwa - Institute Rotary Cancer Hospital, All India Institute of Medical Sciences

基本信息

浏览量：8

职业迁徙

个人简介

My graduate work focused on to develop various novel lipid based drug delivery systems namely nanoemulsifying preconcentrate, polymeric Self-emulsifying nanocapsules, and polymeric enteric nanospheres to deliver anti-cancer agents for local pathologies.

研究兴趣

论文共 61 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Real-World, Single-Center Experience on the Outcomes of Neoadjuvant Chemotherapy and Trastuzumab Alone or in Combination with Pertuzumab in Human Epidermal Growth Factor Receptor 2 Breast Cancer Patients

Ashok Kumar Vaid,Devender Sharma,Jyoti Wadhwa,Rajeev Kumar Agarwal,Kanchan Kaur,Shina Goyal,Dheeraj Gautam,Jyoti Arora,Sabhyata Gupta,Ruchika Goel,Ashok Sen

Journal of Clinical Oncologyno. 16_suppl (2023): e12589-e12589

引用0浏览0引用

1217P Clinical Evaluation of a CE-IVD Liquid Biopsy Pan Cancer Genomic Profiling Test

T. Crook, M. Agarwal,J. Wadhwa,N. Shrivastava,S. Apurwa, H. Darokar,R. Datar,D. Akolkar,S. Schuster, A. Gaya,V. Datta, D. S. Patil, A. Saha, S. Sahni,S. Limaye

Annals of Oncology (2023): S715-S715

引用0浏览0引用

Abstract P4-07-62: Real-World, Single-Center Experience on the Outcomes of Neoadjuvant Chemotherapy and Trastuzumab Alone or in Combination with Pertuzumab in Human Epidermal Growth Factor Receptor 2 Breast Cancer Patients

Ashok K. Vaid,Devender Sharma,Jyoti Wadhwa,Rajeev Agarwal,Kanchan Kaur,Shina Goyal,Dheeraj Gautam,Jyoti Arora,Sabhyata Gupta,Ashok Sen,Ruchika K. Goel, Shagun Mahajan

Cancer researchno. 5_Supplement (2023): P4-62

引用0浏览0引用

Optimizing premenopausal HR+HER2-ve eBC management in India: Insights from expert consensus

A. K. Vaid, O. Pagani, A. C. Ramesh,A. Bharthuar, C. J. Desai, G. Biswas,J. Wadhwa,P. N. Mohapatra,S. Gulia, P. V. S. S. Sripada,T. P. Sahoo, V. Agarwal, F. Dawer, R. R. Desai,K. Gaurav, B. P. Kotak

ANNALS OF ONCOLOGY (2023): S1473-S1473

引用0浏览0引用

Total Ablative Stereotactic Body Radiotherapy to Primary and Oligometastatic Renal Cell Carcinoma in Medically Inoperable Cases: an Institutional Analysis